05:08:17 EDT Thu 06 May 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:MORF from 2020-05-07 to 2021-05-06 - 23 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2021-04-29 08:00U:MORFNews ReleaseMorphic Announces Corporate Highlights and First Quarter 2021 Financial Results
2021-04-28 16:01U:MORFNews ReleaseMorphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors
2021-04-12 08:00U:MORFNews ReleaseMorphic Therapeutic Presents Preclinical Data from av Ÿ8 Integrin Program at American Association for Cancer Research (AACR) Annual Meeting
2021-03-02 20:25U:MORFNews ReleaseMorphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
2021-03-01 16:01U:MORFNews ReleaseMorphic Therapeutic Announces Proposed Public Offering
2021-03-01 07:00U:MORFNews ReleaseMorphic Reports Positive Interim Results from Single Ascending Dose Phase 1 Clinical Trial of MORF-057
2021-03-01 06:55U:MORFNews ReleaseMorphic Announces Corporate Highlights and Financial Results for the Full Year 2020
2021-02-22 08:00U:MORFNews ReleaseMorphic Therapeutic to Host Analyst and Investor Call on March 1, 2021
2021-02-16 16:05U:MORFNews ReleaseMorphic Therapeutic to Participate in GI/Microbiome Panel Discussion at the 41st Annual Cowen Health Care Conference
2021-01-05 08:00U:MORFNews ReleaseMorphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
2020-12-30 08:00U:MORFNews ReleaseMorphic Therapeutic to Present at the Virtual 39th Annual J.P. Morgan Healthcare Conference
2020-12-04 08:00U:MORFNews ReleaseMorphic Therapeutic Announces Appointment of Dr. Martin W. Edwards as Member of its Board of Directors
2020-11-17 09:05U:MORFNews ReleaseMorphic Therapeutic to Present at the Jefferies Virtual London Healthcare Conference
2020-11-09 07:00U:MORFNews ReleaseMorphic Announces Corporate Highlights and Third Quarter 2020 Financial Results
2020-10-12 07:00U:MORFNews ReleaseMorphic Announces Presentation of New Data Supporting Development of MORF-057 at UEG Week Virtual 2020
2020-09-23 06:30U:MORFNews ReleaseMorphic Therapeutic Announces First Healthy Volunteers Dosed in Phase 1 Clinical Trial of MORF-057
2020-09-21 16:45U:MORFNews ReleaseMorphic Therapeutic to Present at the Jefferies Next Generation IBD Therapeutics Virtual Summit
2020-09-03 16:30U:MORFNews ReleaseMorphic Announces Participation in Upcoming Investor Conferences
2020-08-25 06:30U:MORFNews ReleaseMorphic Announces that AbbVie Exercises License Option to av Ÿ6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic Diseases
2020-08-10 07:00U:MORFNews ReleaseMorphic Announces Corporate Highlights and Second Quarter 2020 Financial Results
2020-06-29 07:30U:MORFNews ReleaseMorphic Therapeutic Presents Positive Preclinical Data Supporting Development of MORF-057 in Inflammatory Bowel Disease at Digestive Disease Week 2020
2020-06-18 08:00U:MORFNews ReleaseMorphic to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
2020-05-27 08:00U:MORFNews ReleaseMorphic to Present at the Jefferies Virtual Healthcare Conference